Healthcare Professional Blog

Education Library

Kaplan-Meier-Kurve DanGer Shock RCT. Kaplan-Meier-Kurve DanGer Shock RCT.

DanGer Shock Discussion with Jacob Møller at TCT 2024

Jacob Møller, MD, and Chuck Simonton, MD, discuss the DanGer Shock RCT and new data presented at TCT 2024.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Filter Results

Condition

Audience

Topic

Type

ESC 2023: Predictors of 90-day Outcomes from York Analysis

Vasileios Panoulas, MD, discusses a pooled analysis of factors predicting outcomes at 90 days in high-risk PCI patients.

Revascularization Completeness with pVAD vs IABP

In a third-party analysis conducted by the York Health Economics Consortium was evaluated to test the hypothesis that percutaneous coronary intervention (PCI) with Impella® support...

EuroPCR 2023: Best Practice Approach to High-risk PCI 

Nikos Werner, MD, discusses best practices for high-risk percutaneous coronary interventions (HRPCI) at EuroPCR 2023.

Pre-Procedural Clinical Workup for Protected PCI

Fadi Al-Rashid, MD, discusses his publication on standard pre-procedural clinical workup for Protected PCI.

Optimized Patient Selection for High-risk Protected PCI

Jürgen Leick, MD, discusses his paper on optimizing patient selection in high-risk protected percutaneous coronary intervention.

Optimal Revascularization Strategies During Protected PCI

Prof. Dr. Jan-Malte Sinning discusses optimal revascularization strategies during protected high-risk procedures with Impella® heart pumps.

Renal Protection and Hemodynamic Improvement by Impella® Heart Pumps

Birgit Markus, MD, discusses data on the impact of Impella® heart pump support on hemodynamics and renal function in patients with cardiogenic shock.

Vandenbriele: Anticoagulation and Protected PCI

Prof. Dr. Christophe Vandenbriele discusses his recently published paper on anticoagulation in patients undergoing Protected PCI procedures.

FAQ: Anticoagulation

This FAQ addresses thrombus formation and anticoagulation for blood-contacting medical devices, such as the Impella® heart pump.

Heparin-free Purge Help Manage Anticoagulation in Patients Supported with Impella Heart Pumps

Prof. Dr. Christophe Vandenbriele discusses managing anticoagulation in patients supported with Impella CP with SmartAssist heart pumps and the use of bicarbonate-based purge fluid.

Early Left Ventricular Unloading Improves Survival in Patients With Cardiogenic Shock Undergoing Extracorporeal Membrane Oxygenation (ECMO)

Dr. Andreas Götzenich interviews Dr. Benedikt Schrage from Hamburg on the topic "Early left ventricular unloading improves survival in patients with cardiogenic shock undergoing extracorporeal membrane oxygenation (ECMO)".

Improving Survival in Cardiogenic Shock — A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support

In this paper, Sascha Ott and colleagues describe a standard operating procedure (SOP) they developed for determining the temporary mechanical circulatory support (tMCS) strategy for patients in cardiogenic shock (CS).

How to Achieve Better Outcomes in PCCS

Prof. Dr. med. Gregor Warnecke discusses how to achieve better outcomes in patients with postcardiotomy cardiogenic shock (PCCS).

The ECMELLA 2+ Concept

Prof. Evgenij Potapov explains how “ECMELLA 2+” achieves over 50% survival in patients with very severe cardiogenic shock while minimizing complications and enabling mobilization.

Subscribe for Our Healthcare Professional Newsletter

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.

CAMP PCI™

Professional Education Events

Learn more about upcoming events and courses.

Downloads

Discover further resources like brochures, data sheets and indications for use.

NPS-4998

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].